GlassScriptPhysician profile
Cory Davenport
NPI 1730337858
$4,935.41
in general payments reported to CMS, 2019-2025
12 companies · $1,834 in 2025
The $1,834 reported for 2025 was more than what 95% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $320 · 2022: $2,112 · 2023: $311 · 2024: $358 · 2025: $1,834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,860 · Travel and Lodging: $643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,859.88 |
| Travel and Lodging | $643.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $1,995.57 | 2021-2024 | Vasoview Hemopro 2 |
| Abiomed | $1,932.50 | 2021-2025 | Impella |
| Abbott Laboratories | $276.21 | 2023-2025 | Mitraclip, Ensite Precision, Xience Skypoint |
| Edwards Lifesciences Corporation | $175.23 | 2022 | |
| Baxter Healthcare | $136.42 | 2025 | |
| Biosense Webster, INC. | $112.93 | 2023 | Qdot Micro Catheter |
| Pfizer INC. | $89.50 | 2022 | |
| Medtronic, INC. | $76.71 | 2024-2025 | Penditure, Azure Xt Dr Mri Surescan |
| Terumo Cardiovascular Systems Corporation | $56.59 | 2022 | |
| Shockwave Medical, INC | $40.41 | 2021-2025 | |
| Boston Scientific Corporation | $22.32 | 2025 | Watchman Flx |
| Biotronik INC. | $21.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Davenport listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.